ATC Abstracts

American Transplant Congress abstracts

2017 American Transplant Congress » Concurrent Session: Clinical Science: Kidney Immunosuppression: Desensitization

Date: Sunday, April 30, 2017

Time: 4:30pm-6:00pm

Location: E354b

Session Type: Concurrent Session

Meeting: 2017 American Transplant Congress

4:30pm-4:42pm
Desensitization versus Deceased Donor Kidney Transplantation: What to Choose When Both Become Available?

B. Orandi,1 X. Luo,2 J. Garonzik-Wang,2 R. Montgomery,3 D. Segev.2

4:42pm-4:54pm
Even with National Sharing, the Prospects of a 100% Sensitized Patient Receiving a Transplant Vary Dramatically Depending on the Precise CPRA Value.

D. Stewart,1 A. Kucheryavaya,1 D. Tyan,2 H. Gebel,3 R. Bray,3 N. Turgeon.3

4:54pm-5:06pm
A Prospective Iterative Trial of Carfizomib-Based Desensitization Trial: Initial Comparative Observations.

S. Tremblay,1 A. Shields,1,2 R. Alloway,1 P. Brailey,1 A. Leino,1 A. Lichvar,1 B. Abu Jawdeh,1 J. Driscoll,1 A. Girnita,1 E. Woodle.1

5:06pm-5:18pm
Induction of Proliferative Responses in B Cell and Plasma Cell Populations Following Proteasome Inhibitor Desensitization Treatment in Rhesus Macacques and Humans.

J. Driscoll,1 S. Knechtle,2 J. Kwun,2 S. Tremblay,1 N. Salomonis,3 S. Potter,3 B. Aronow,3 M. Manook,2 R. Alloway,1 H. Singh,3 E. Woodle.1

5:18pm-5:30pm
In Vivo Administration of Plerixafor in Humans Mobilizes Bone Marrow Resident Plasma Cells That Demonstrate Apoptosis in Both Bone Marrow and Peripheral Blood.

E. Woodle, S. Tremblay,1 C. Castro-Rojas,2 J. Driscoll,1 S. Knechtle,3 A. Shields,1 R. Alloway,1 D. Hildeman.2

5:30pm-5:42pm
Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant.

A. Vo, J. Choi, I. Kim, E. Huang, S. Louie, A. Kang, S. Williamson, K. Myers, A. Peng, R. Najjar, S. Jordan.

5:42pm-5:54pm
Characterization of Human Plasma Cell Proteasome Adaptations to Proteasome Inhibitor Therapy: A Precision Medicine Approach to Overcome Drug Resistance in Desensitization.

J. Driscoll,1 S. Tremblay,1 P. Brailey,1 A. Girnita,1 R. Alloway,1 B. Aronow,2 H. Singh,2 E. Woodle.2

« View all sessions from the 2017 American Transplant Congress